Cargando…
C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer’s model
Alzheimer’s disease (AD) is the leading cause of dementia in older adults, and the need for effective, sustainable therapeutic targets is imperative. Pharmacologic inhibition of C5aR1 reduces plaque load, gliosis and memory deficits in animal models. However, the cellular basis underlying this neuro...
Autores principales: | Schartz, Nicole D., Liang, Heidi Y., Carvalho, Klebea, Chu, Shu-Hui, Mendoza-Arvilla, Adrian, Petrisko, Tiffany J., Gomez-Arboledas, Angela, Mortazavi, Ali, Tenner, Andrea J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473603/ https://www.ncbi.nlm.nih.gov/pubmed/37662399 http://dx.doi.org/10.1101/2023.08.22.554306 |
Ejemplares similares
-
C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer’s disease
por: Gomez-Arboledas, Angela, et al.
Publicado: (2022) -
Modulation of C5a–C5aR1 signaling alters the dynamics of AD progression
por: Carvalho, Klebea, et al.
Publicado: (2022) -
C5aR1 signaling promotes region and age dependent synaptic pruning in models of Alzheimer’s Disease
por: Gomez-Arboledas, Angela, et al.
Publicado: (2023) -
Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer’s mouse models
por: Petrisko, Tiffany J., et al.
Publicado: (2023) -
The good, the bad, and the opportunities of the complement system in neurodegenerative disease
por: Schartz, Nicole D., et al.
Publicado: (2020)